Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Gross Margin (2020 - 2025)

Agilon Health (AGL) has disclosed Gross Margin for 6 consecutive years, with 105.66% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 1497.0% year-over-year to 105.66%, compared with a TTM value of 99.88% through Dec 2025, up 932.0%, and an annual FY2025 reading of 99.88%, up 340.0% over the prior year.
  • Gross Margin was 105.66% for Q4 2025 at Agilon Health, up from 99.06% in the prior quarter.
  • Across five years, Gross Margin topped out at 209.41% in Q4 2022 and bottomed at 6.98% in Q4 2021.
  • Average Gross Margin over 5 years is 78.16%, with a median of 94.38% recorded in 2023.
  • The sharpest move saw Gross Margin soared 20243bps in 2022, then tumbled -13618bps in 2023.
  • Year by year, Gross Margin stood at 6.98% in 2021, then surged by 2898bps to 209.41% in 2022, then crashed by -65bps to 73.23% in 2023, then grew by 24bps to 90.69% in 2024, then grew by 17bps to 105.66% in 2025.
  • Business Quant data shows Gross Margin for AGL at 105.66% in Q4 2025, 99.06% in Q3 2025, and 96.69% in Q2 2025.